Talbot D - Search Results

1

Evaluation of daclizumab to reduce delayed graft function in non-heart-beating renal transplantation: a prospective, randomized trial.

Wilson C, Brook NR, Gok MA, Gupta A, Asher JF, Nicholson ML, Talbot D. Wilson C, et al. Among authors: talbot d. Transplant Proc. 2005 May;37(4):1774-5. doi: 10.1016/j.transproceed.2005.02.079. Transplant Proc. 2005. PMID: 15919462 Clinical Trial.

2

Improved graft outcome and reduced complications due to flow cytometric crossmatching and DR matching in renal transplantation.

Talbot D, Cavanagh G, Coates E, Givan AL, Shenton BK, Lennard TW, Proud G, Taylor RM. Talbot D, et al. Transplantation. 1992 Apr;53(4):925-8. doi: 10.1097/00007890-199204000-00039. Transplantation. 1992. PMID: 1566358

3

Use of flow cytometric crossmatching in cardiac transplantation.

Shenton BK, Glenville BE, Mitcheson AE, Coates E, Talbot D, Givan AL, Kirk A, Dark JH. Shenton BK, et al. Among authors: talbot d. Transplant Proc. 1991 Feb;23(1 Pt 2):1153-4. Transplant Proc. 1991. PMID: 1989175 No abstract available.

4

The prospective value of the preoperative flow cytometric crossmatch assay in renal transplantation.

Talbot D, Givan AL, Shenton BK, Stratton A, Coates E, Parrott NR, Forsythe JL, Rigg K, Lennard TW, Proud G, et al. Talbot D, et al. Transplantation. 1990 Apr;49(4):809-10. Transplantation. 1990. PMID: 2326875 No abstract available.

5

Renal allograft rejection. Possible involvement of antibody-dependent cell-mediated cytotoxicity.

Kirby JA, Givan AL, Shenton BK, Talbot D, Forsythe JL, Lennard TW, Proud G, Taylor RM. Kirby JA, et al. Among authors: talbot d. Transplantation. 1990 Aug;50(2):225-9. doi: 10.1097/00007890-199008000-00010. Transplantation. 1990. PMID: 2382289

6

The relevance of a more sensitive crossmatch assay to renal transplantation.

Talbot D, Givan AL, Shenton BK, Stratton A, Proud G, Taylor RM. Talbot D, et al. Transplantation. 1989 Mar;47(3):552-5. doi: 10.1097/00007890-198903000-00030. Transplantation. 1989. PMID: 2646784

7

Value of the flow cytometric crossmatch in renal transplantation.

Talbot D, Givan AL, Shenton BK, Parrott NR, Wilson RG, Lennard TW, Proud G, Taylor RM. Talbot D, et al. Transplant Proc. 1987 Oct;19(5):4315-6. Transplant Proc. 1987. PMID: 3314034 No abstract available.

8

Reversal of steroid-resistant rejection in renal allograft recipients using FK506.

Mathew A, Talbot D, Minford EJ, Rix D, Starkey G, Forsythe JL, Proud G, Taylor RM. Mathew A, et al. Among authors: talbot d. Transplantation. 1995 Nov 27;60(10):1182-4. doi: 10.1097/00007890-199511270-00022. Transplantation. 1995. PMID: 7482730 No abstract available.

9

Developing the ideal immunosuppressive protocol by internal audit.

Talbot D, Reddy KS, Watson D, Pleass H, Forsythe JL, Proud G, Ross Taylor RM. Talbot D, et al. Transpl Int. 1995;8(5):392-5. doi: 10.1007/BF00337172. Transpl Int. 1995. PMID: 7576022

10

The clinical significance of post-transplantation non-HLA antibodies in renal transplantation.

al-Hussein KA, Talbot D, Proud G, Taylor RM, Shenton BK. al-Hussein KA, et al. Among authors: talbot d. Transpl Int. 1995;8(3):214-20. doi: 10.1007/BF00336540. Transpl Int. 1995. PMID: 7626182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

640 results

Search Page

Filters